Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Non Operating Income (2017 - 2025)

Prestige Consumer Healthcare has reported Other Non Operating Income over the past 15 years, most recently at -$10.0 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$10.0 million for Q4 2025, down 2734.28% from a year ago — trailing twelve months through Dec 2025 was -$14.0 million (down 1616.81% YoY), and the annual figure for FY2025 was -$5.0 million, down 755.29%.
  • Other Non Operating Income for Q4 2025 was -$10.0 million at Prestige Consumer Healthcare, down from -$501000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for PBH hit a ceiling of $1.4 million in Q1 2021 and a floor of -$10.0 million in Q4 2025.
  • Median Other Non Operating Income over the past 5 years was -$487000.0 (2022), compared with a mean of -$944947.4.
  • Biggest five-year swings in Other Non Operating Income: surged 1150.0% in 2021 and later tumbled 2734.28% in 2025.
  • Prestige Consumer Healthcare's Other Non Operating Income stood at -$2.1 million in 2021, then skyrocketed by 45.81% to -$1.2 million in 2022, then surged by 40.7% to -$682000.0 in 2023, then skyrocketed by 48.24% to -$353000.0 in 2024, then tumbled by 2734.28% to -$10.0 million in 2025.
  • The last three reported values for Other Non Operating Income were -$10.0 million (Q4 2025), -$501000.0 (Q3 2025), and $224000.0 (Q2 2025) per Business Quant data.